Titlebook: An Introduction to Bioanalysis of Biopharmaceuticals; Seema Kumar Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi

Facet-Joints

An Introduction to Bioanalysis of Biopharmaceuticals978-3-030-97193-9Series ISSN 2210-7371 Series E-ISSN 2210-738X

不整齊

Introduction,(LC-MS) have been the work?horse for large-molecule and small-molecule therapeutics, respectively. However, the expansion of therapeutic modalities beyond the conventional realms of large-molecule and small-molecule therapeutics has led to the increased utility of combination of LBA and LC-MS approa

leniency

Gene Therapy and Cell Therapy: Bioanalytical Challenges and Practical Solutions,ays (LBA) and liquid chromatography coupled mass spectrometry?(LC-MS) platforms. Likewise, the bioanalytical strategy for chimeric antigen receptor (CAR) protein on CAR-T-cells also demands unique analytical?platforms such as polymerase chain reaction (PCR). The regulatory expectations on bioanalyti

Vulvodynia

連接

accomplishment

準(zhǔn)則

心胸開闊

An Introduction to Bioanalysis of Biopharmaceuticals

我悲傷

Aerophagia

https://doi.org/10.1007/978-3-658-12031-3dditional considerations?due to the complexity of their?structure, additional domain-specific critical reagent generation, and increased assay complexities?due to interferences observed by?individual?functional domains.